Key result
Mitral valve repair and mitral valve replacement resulted in similar 5-year survival rates in patients with chronic ischemic mitral regurgitation and left ventricular dysfunction, though replacement provided better long-term correction of mitral regurgitation.
Why the study?
Does mitral valve repair improve survival and left ventricular remodeling compared to mitral valve replacement in patients with chronic ischemic mitral regurgitation and left ventricular dysfunction?
Cohort (n=218)
No
Does mitral valve repair improve survival and left ventricular remodeling compared to mitral valve replacement in patients with chronic ischemic mitral regurgitation and left ventricular dysfunction?
In patients with severe ischemic mitral regurgitation and left ventricular dysfunction, mitral valve replacement may offer better long-term left ventricular reverse remodeling and lower MR recurrence than repair, despite similar long-term survival.
Answers are grounded in this paper and cite their sources.
Survival equivalent after repair or replacement in ischemic MR with LV dysfunction; leaves open optimal strategy pending randomized trials.
BACKGROUND: This study was undertaken to compare mitral valve repair and replacement as treatments for ischemic mitral regurgitation (IMR) with left ventricular dysfunction (LVD). Specifically, we sought to determine whether the choice of mitral valve procedure affected survival, and discover which patients were predicted to benefit from mitral valve repair and which from replacement. METHODS: A total of 218 consecutive patients underwent either mitral valve repair (MVP, n = 112) or mitral valve replacement (MVR, n = 106). We retrospectively reviewed the clinical material, operation methods, echocardiography check during operation and follow-up. Patients details and follow-up outcomes were compared using multivariate and Kaplan-Meier analyses. RESULTS: No statistical difference was found between the two groups in term of intraoperative data. Early mortality was 3.2% (MVP 2.7% and MVR 3.8%). At discharge, Left ventricular end-systolic and end-diastolic diameter and left ventricular ejection fraction (LVEF) were improved more in the MVP group than MVR group (P < 0.05), however, in follow-up no statistically significant difference was observed between the MVR and MVP group (P > 0.05). Follow-up mitral regurgitation grade was significantly improved in the MVR group compared with the MVP group (P < 0.05). The Kaplan-Meier survival estimates at 1, 3, and 5 years were similar between MVP and MVR group. Logistic regression revealed poor survival was associated with old age(#75), preoperative renal insufficiency and low left ventricular ejection fraction (< 30%). CONCLUSION: Mitral valve repair is the procedure of choice in the majority of patients having surgery for severe ischemic mitral regurgitation with left ventricular dysfunction. Early results of MVP treatment seem to be satisfactory, but several lines of data indicate that mitral valve repair provided less long-term benefit than mitral valve replacement in the LVD patients.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2010) conducted a cohort in Chronic ischemic mitral regurgitation with left ventricular dysfunction (n=218). Mitral valve repair vs. Mitral valve replacement was evaluated on 5-year survival (p=>0.05). Mitral valve repair and mitral valve replacement resulted in similar 5-year survival rates in patients with chronic ischemic mitral regurgitation and left ventricular dysfunction, though replacement provided better long-term correction of mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: